EID Parry acquires Bayer’s nutraceuticals arm Alimtec in Chlie

26 Apr 2014

Alimtec makes Haematococcus pluvialis biomass, a cultured micro-algae, which is a rich natural source of Astaxanthin for human use

Delhi HC bars export of Natco's generic cancer drug on Bayer’s plea

27 Mar 2014

Bayer, in its petition, has pointed out that the generic drug being made under compulsory licence is for sale in India and, thus, cannot be exported

Bayer to buy Chinese traditional herbal medicine maker Dihon Pharmaceutical

28 Feb 2014

Bayer close to bagging cancer drug maker Algeta for $2.9-bn

24 Feb 2014

German healthcare major Bayer AG today said that it is close to completing its $2.9-billion acquisition of Algeta, after 92.17 per cent shareholders of the Norwegian cancer drug maker tendered their shares to the offer

Bayer, Novartis, Reckitt Benckiser, P&G in fray for Merck & Co's consumer healthcare unit

20 Feb 2014

Bayer, Novartis, Reckitt Benckiser, and Procter & Gamble are among the companies that are exploring a deal to buy Merck &Co's consumer healthcare unit

Bayer to acquire cancer drug maker Algeta

19 Dec 2013

Bayer and Algeta are partners in the sale of the prostate cancer drug Xofigo, which the US FDA had approved in May

EU restrict pesticides use to protect bees

25 May 2013

Bayer AG to acquire herbal drug maker Steigerwald Arzneimittelwerk

17 May 2013

Bayer to acquire contraception device maker Conceptus for $1.1 bn

29 Apr 2013

Bayer loses cancer drug patent case

04 Mar 2013

The ruling ensures that cancer patients would be able to buy generic Nexavar at Rs8,800 for a month’s dose against Rs2,80,000 for Bayer’s branded Nexavar

Sanofi still in the race for Bayer’ blood glusose testing business: report

08 Dec 2012

Bayer clinches deal for sale of Thane land

30 Nov 2012

Bayer backs out from bidding war with Reckitt Benckiser over US vitamins maker Schiff Nutrition

20 Nov 2012

Bayer to buy US vitamins maker Schiff Nutrition International for $1.2 bn

30 Oct 2012

Bayer HealthCare to buy Teva Pharma' US animal health business for$145 mn

14 Sep 2012

Bayer appeals against grant of ‘Nexavar’ licence to Natco

07 May 2012

Piramal Healthcare buys Bayer’s molecular imaging and research portfolio

16 Apr 2012

The acquisition includes Florbetaben, a drug candidate for diagnosis of Alzheimer’s disease that is in the final stages of clinical trials, with potential to generate annual revenues of $1.5 billion

Natco granted compulsory licence for Bayer's Nexavar

12 Mar 2012

The compulsory licence, the first of its kind to be granted in India, enables Natco to sell the drug at up to Rs8,880 for a pack of 120 tablets against Rs284,428 for Bayer's Nexavar

Bayer to continue focus on farm products with fresh capex

17 Nov 2011

Bayer unit to pay $750-mn for GM rice lawsuits to US farmers

02 Jul 2011

DB backs out of Bayer deal following Balwa arrest

12 Feb 2011

Bayer opens emissions-neutral office building in India

21 Jan 2011

Bayer to invest €1 bn in five projects in China

09 Dec 2010

SC rejects Bayer plea against generic Cipla drug

02 Dec 2010

Bayer develops raw materials for solar-powered refrigerators

26 Aug 2010